Inventor · disambiguated record
Ekambar Kandimalla
Also filed as: KANDIMALLA EKAMBAR · KANDIMALLA EKAMBAR B · KANDIMALLA EKAMBAR R
78 granted patents·42 pending applications·2,275 citations·filing 1995–2025
99Inventor score
Files withIDERA PHARMACEUTICALS INC64HYBRIDON INC14AGRAWAL SUDHIR10KANDIMALLA EKAMBAR8KANDIMALLA EKAMBAR R8
Top patents by PatentIndex Score
120 records- 0198US8202850B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsAGRAWAL SUDHIR·Filed 2010·Granted Jun 19, 2012·60 cites·17 claims
- 0298US7812000B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2007·Granted Oct 12, 2010·66 cites·18 claims
- 0398US7427405B2Immunostimulatory oligonucleotide multimersIDERA PHARMACEUTICALS INC·Filed 2005·Granted Sep 23, 2008·40 cites·7 claims
- 0498US7276489B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2002·Granted Oct 2, 2007·221 cites·22 claims
- 0598US6383752B1Pseudo-cyclic oligonucleobasesHYBRIDON INC·Filed 2000·Granted May 7, 2002·200 cites·33 claims
- 0697US7566702B2Immunostimulatory oligonucleotide multimersIDERA PHARMACEUTICALS INC·Filed 2005·Granted Jul 28, 2009·28 cites·7 claims
- 0797US7498425B2Immunostimulatory oligonucleotide multimersIDERA PHARMACEUTICALS INC·Filed 2005·Granted Mar 3, 2009·28 cites·7 claims
- 0897US7498426B2Immunostimulatory oligonucleotide multimersIDERA PHARMACEUTICALS INC·Filed 2005·Granted Mar 3, 2009·28 cites·7 claims
- 0996US9453228B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2015·Granted Sep 27, 2016·21 cites·24 claims
- 1096US8431544B1Compositions for inhibiting gene expression and uses thereofAGRAWAL SUDHIR·Filed 2010·Granted Apr 30, 2013·48 cites·16 claims
- 1196US7517862B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2004·Granted Apr 14, 2009·64 cites·9 claims
- 1296US7470674B2Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS INC·Filed 2005·Granted Dec 30, 2008·48 cites·19 claims
- 1396US5886165AMixed backbone antisense oligonucleotides containing 2'-5'-ribonucleotide- and 3'-5'-deoxyribonucleotides segmentsHYBRIDON INC·Filed 1996·Granted Mar 23, 1999·206 cites·15 claims
- 1495US7407944B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2004·Granted Aug 5, 2008·56 cites·6 claims
- 1595US7405285B2Immunostimulatory oligonucleotide multimersIDERA PHARMACEUTICALS INC·Filed 2005·Granted Jul 29, 2008·35 cites·7 claims
- 1695US7105495B2Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosidesIDERA PHARMACEUTICALS INC·Filed 2003·Granted Sep 12, 2006·48 cites·3 claims
- 1794US8426375B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseKANDIMALLA EKAMBAR·Filed 2008·Granted Apr 23, 2013·25 cites·15 claims
- 1894US7709617B2Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapyIDERA PHARMACEUTICALS INC·Filed 2005·Granted May 4, 2010·18 cites·7 claims
- 1994US7262286B2Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changesIDERA PHARMACEUTICALS INC·Filed 2001·Granted Aug 28, 2007·42 cites·5 claims
- 2094US7176296B2Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosidesIDERA PHARMACEUTICALS INC·Filed 2003·Granted Feb 13, 2007·52 cites·4 claims
- 2193US7632822B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS INC·Filed 2005·Granted Dec 15, 2009·17 cites·7 claims
- 2293US5693773ATriplex-forming antisense oligonucleotides having abasic linkers targeting nucleic acids comprising mixed sequences of purines and pyrimidinesHYBRIDON INC·Filed 1995·Granted Dec 2, 1997·118 cites·14 claims
- 2392US8399423B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseKANDIMALLA EKAMBAR·Filed 2008·Granted Mar 19, 2013·12 cites·12 claims
- 2492US8383598B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2008·Granted Feb 26, 2013·12 cites·13 claims
- 2592US8008267B2Stabilized immunomodulatory oligonucleotidesIDERA PHARMACEUTICALS INC·Filed 2004·Granted Aug 30, 2011·29 cites·16 claims
- 2692US7960362B2Synthetic agonists of TLR9IDERA PHARMACEUTICALS INC·Filed 2008·Granted Jun 14, 2011·19 cites·6 claims
- 2792US7595305B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS·Filed 2005·Granted Sep 29, 2009·21 cites·7 claims
- 2892US7115579B2Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosidesIDERA PHARMACEUTICALS INC·Filed 2001·Granted Oct 3, 2006·38 cites·8 claims
- 2991US8361986B2Synthetic agonists of TLR9IDERA PHARMACEUTICALS INC·Filed 2011·Granted Jan 29, 2013·18 cites·6 claims
- 3091US7875594B2Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agentsIDERA PHARMACEUTICALS INC·Filed 2008·Granted Jan 25, 2011·11 cites·7 claims
- 3191US7786089B2Immunostimulatory activity of immune modulatory oligonucleotides (IMO™) containing different lengths of palindromic segmentsIDERA PHARMACEUTICALS INC·Filed 2006·Granted Aug 31, 2010·14 cites·8 claims
- 3291US7569554B2Synergistic treatment of cancer using immunomers in conjunction with therapeutic agentsIDERA PHARMACEUTICALS INC·Filed 2004·Granted Aug 4, 2009·23 cites·2 claims
- 3391US7354907B2Short immunomodulatory oligonucleotidesIDERA PHARMACEUTICALS INC·Filed 2003·Granted Apr 8, 2008·38 cites·1 claims
- 3490US8853375B2Toll like receptor modulatorsKANDIMALLA EKAMBAR·Filed 2008·Granted Oct 7, 2014·17 cites·7 claims
- 3590US7884197B2Synthetic agonists of TLR9IDERA PHARMACEUTICALS INC·Filed 2007·Granted Feb 8, 2011·13 cites·5 claims
- 3690US7863250B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS INC·Filed 2005·Granted Jan 4, 2011·9 cites·7 claims
- 3790US7749975B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2005·Granted Jul 6, 2010·9 cites·8 claims
- 3890US5912332AAffinity-based purification of oligonucleotides using soluble multimeric oligonucleotidesHYBRIDON INC·Filed 1996·Granted Jun 15, 1999·140 cites·14 claims
- 3990US5739308AIntegrated oligonucleotidesHYBRIDON INC·Filed 1995·Granted Apr 14, 1998·106 cites·4 claims
- 4089US8486908B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseKANDIMALLA EKAMBAR R·Filed 2011·Granted Jul 16, 2013·11 cites·16 claims
- 4189US8377898B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2007·Granted Feb 19, 2013·15 cites·13 claims
- 4289US8357665B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2006·Granted Jan 22, 2013·10 cites·15 claims
- 4389US8188261B2Stabilized immune modulatory RNA (SIMRA) compoundsKANDIMALLA EKAMBAR·Filed 2008·Granted May 29, 2012·13 cites·5 claims
- 4489US8153608B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesAGRAWAL SUDHIR·Filed 2010·Granted Apr 10, 2012·9 cites·12 claims
- 4589US7776834B2Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS INC·Filed 2005·Granted Aug 17, 2010·12 cites·31 claims
- 4688US9096858B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2013·Granted Aug 4, 2015·8 cites·8 claims
- 4788US7833538B2Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changesIDERA PHARMACEUTICALS INC·Filed 2005·Granted Nov 16, 2010·6 cites·4 claims
- 4887US9260719B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2014·Granted Feb 16, 2016·8 cites·10 claims
- 4987US8476416B2Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changesKANDIMALLA EKAMBAR R·Filed 2006·Granted Jul 2, 2013·6 cites·11 claims
- 5087US8106173B2Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8KANDIMALLA EKAMBAR R·Filed 2007·Granted Jan 31, 2012·9 cites·14 claims
Showing the top 50 of 120 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →